Boiron takes a hit from French homeopathy move
27 April 2020
Boiron's sales in its home market of France dropped by 12.7% in the first quarter of 2020, following changes to the reimbursement of homeopathic medicines.
Industry News - Tag: Boiron
You can read Premium News stories in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
People in brief | CHPA, Boiron, Angelini
15 April 2020
The US Consumer Healthcare Products Association (CHPA) has elected a new chair, Boiron has announced a change to its board and Angelini Pharma has made a promotion.
Boiron to close facilities and cut jobs in France
Premium
11 March 2020
Boiron has announced major cuts to its organisation in the wake of the French government’s progressive end to reimbursement of homeopathic medicines.
Boiron feels impact of French homeopathy move
30 January 2020
Boiron's sales in its home market of France dropped by 12.6% in 2019, following a long debate about the pros and cons of homeopathy.
French homeopathy decision impacts Boiron
Premium
24 July 2019
Boiron's sales in its home market of France dropped by 10.5% in the first half of 2019 as the government announced plans to end reimbursement of homeopathic medicines.
Industry in brief | Boiron, Taisho/UPSA, BioGaia
2 July 2019
Boiron has criticised a French recommendation on homoeopathy, Taisho Pharmaceutical has completed its planned acquisition of UPSA, and BioGaia has announced a deal with Abbott in Uruguay.
Homoeopathy debate hurts Boiron in France
3 May 2019
Boiron said sales in its home market of France fell by 9.3% in the first quarter of 2019 as the country debated whether homoeopathy should be delisted from reimbursement.
Boiron reports significant sales drop in Europe
Premium
28 January 2019
French homoeopathy specialist Boiron reported a significant sales decline in Europe during 2018 but achieved strong growth in the rest of the world.